增强器RNAs有助于基因组重编程,由白血病中的GATA3非编码变体驱动
Thayana da Conceição Barbosa1, Caroline Pires Poubel1,2, Ana Luiza Tardem Maciel1
1Genetics of Acute Leukaemia Laboratory (GenLAb), Research Centre, Instituto Nacional de Câncer (INCA), Rua André Cavalcanti, 37, 6th Floor, Rio de Janeiro, RJ, 20231-050, Brazil.
Scientific reports
|August 9, 2025
概括
在GATA3中,一个非编码的变体 (rs3824662) 通过改变染色质来影响类似Ph的B-ALL. 在GATA3附近的增强器RNA (eRNA),特别是 eRNA_G3,与这种变体上调并与CRLF2表达相关.
科学领域:
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 费城染色体样B型急性淋巴细胞白血病 (Ph样B型ALL) 的发病包括遗传改变.
- GATA3非编码变体rs3824662与Ph类B-ALL有关,导致染色质重组和基因失调,包括CRLF2过度表达.
研究的目的:
- 研究GATA3位点附近增强子RNA (eRNA) 在调节CRLF2表达中的作用.
- 探索 GATA3 变体 rs3824662 和 Ph-like B-ALL 中的 eRNA 的合作功能.
主要方法:
- 对GATA3结合区域和染色质可访问性的分析.
- 在 eRNA 表达式和 CRLF2 表达式之间的相关性分析.
- 在Ph类ALL病例中,对eRNA_G3和GATA3变异rs3824662的量化.
主要成果:
- eRNA_G3表达与CRLF2表达正相关.
- 在具有GATA3 rs3824662变异的Ph类ALL病例中,eRNA_G3被显著上调.
- GATA3 变异 rs3824662 与染色体格局的改变以及 GATA3 结合区域的可访问性增加有关.
结论:
- eRNA_G3可能在Ph型B-ALL中对CRLF2表达起调节作用.
- GATA3变体rs3824662和eRNAs可以协同调节Ph类ALL中的GATA3和CRLF2表达.
更多相关视频
相关概念视频
lncRNA - Long Non-coding RNAs
8.9K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.9K
RNA Polymerase II Accessory Proteins
9.5K
Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
9.5K
Lineage Commitment
3.1K
Commitment is the process whereby stem cells:
3.1K
Methods of Nuclear Reprogramming
1.9K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.9K
General Transcription Factors
5.5K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.5K
Chromatin Modification in iPS Cells
1.9K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.9K


